Biotech

All Articles

Boehringer provides to $1.3 B for checkpoint inhibitor biotech

.Boehringer Ingelheim is offering up to $1.3 billion for Nerio Therapeutics and a preclinical immune...

Ventyx's last resort for inflammatory med sides in Crohn's breakdown

.Ventyx Biosciences' Crohn's condition medicine did not aid patients achieve remission in a period 2...

Cognition's period 2 radiate data tarnish Alzheimer's possibility

.Cognition Therapeutics' stage 2 SHINE trial has actually taken a few of the appeal off the Alzheime...

BMS axes bispecific months after filing to function period 3 test

.Bristol Myers Squibb has actually possessed a whiplash change of heart on its BCMA bispecific T-cel...

Charles Baum takes control of Terremoto as CEO

.Charles Baum, M.D., Ph.D., who looked after Mirati Therapeutics' $ 5.8 billion sale to Bristol Myer...

Asarina to shut after attempts to companion Tourette's medication fall short

.After connecting to greater than 200 business to companion a Tourette syndrome treatment that prese...

Novartis markers $150M ahead of time bispecifics handle Dren Bio

.Novartis has possessed some rotten luck along with bispecific antitoxins before, however determinin...

AstraZeneca plants an EGFR tree with Pinetree offer worth $45M

.Pinetree Therapeutics will definitely assist AstraZeneca vegetation some plants in its own pipe alo...

GRO gathers $60M series B to take gout therapy right into clinic

.GRO Biosciences has actually ended the full week along with an extra $60.3 million in the banking c...

Chutes &amp Ladders-- Gilead's Merdad Parsey goes, Cassava sheds CEO

.Accept to recently's Chutes &amp Ladders, our roundup of notable leadership hirings, shootings and ...